Federated Hermes
AXSM icon

Federated Hermes’s Axsome Therapeutics AXSM Stock Holding History

Federated Hermes’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5M Buy
177,842
+69,271
+64% +$15M 0.06% 299
2026
Q1 		$18.4M Buy
108,571
+21,291
+24% +$3.68M 0.03% 492
2025
Q4 		$15.9M Buy
87,280
+29,995
+52% +$4.19M 0.03% 500
2025
Q3 		$6.96M Buy
57,285
+816
+1% +$91.9K 0.01% 666
2025
Q2 		$5.89M Buy
56,469
+30,479
+117% +$3.23M 0.01% 689
2025
Q1 		$3.03M Buy
+25,990
New +$2.96M 0.01% 837
2020
Q4 		– Sell
-7
Closed -$1K – 2242
2020
Q3 		$1K Sell
7
-20,724
-100% -$1.61M ﹤0.01% 2140
2020
Q2 		$1.71M Sell
20,731
-14,307
-41% -$1.1M ﹤0.01% 1046
2020
Q1 		$2.06M Sell
35,038
-4,287
-11% -$349K 0.01% 888
2019
Q4 		$4.07M Buy
39,325
+26,200
+200% +$1.06M 0.01% 827
2019
Q3 		$266K Buy
+13,125
New +$337K ﹤0.01% 1543

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federated Hermes's AXSM Position: Q2 2026 in Review

Federated Hermes increased its Axsome Therapeutics (AXSM) stake by 64% in Q2 2026, buying an estimated $15M and bringing the position to 177,842 shares worth $43.5M. The position accounts for 0.06% of the portfolio, ranked #299.

Federated Hermes first reported a position in AXSM in Q3 2019 and has held it in 11 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Federated Hermes held 177,842 shares of Axsome Therapeutics worth $43.5M as of Q2 2026.
  • Federated Hermes bought 69,271 Axsome Therapeutics shares in Q2 2026, an estimated $15M.
  • Axsome Therapeutics made up 0.06% of Federated Hermes's portfolio in Q2 2026, its #299 holding.
  • Federated Hermes first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 11 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.